Pediatric TRK Fusion-Positive Cancer: Optimizing Care With TRK Inhibitors

Are you up to date on the use of tropomyosin receptor kinase (TRK) inhibitors in pediatric patients with TRK fusion-positive cancers?

Credit available for this activity expires: 11/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pediatric-trk-fusion-positive-cancer-optimizing-care-trk-2024a1000lmh?ecd=bdc_podcast_libsyn_mscpedu